Rigorous economic analysis and expert testimony for attorneys and law firms
Litigation Economics (also referred to as Forensic Economics) refers to the application of economic theory and methods to a variety of disputes and litigation. Avalon Health Economics services in Litigation Economics provides a wide range of services related to the application of theory and tools from the fields of economics, epidemiology, biostatistics, and data analytics to a variety of dispute and litigation settings. Our core competencies are in the intersection of the standard tools of forensic economics and the novel tools of advanced data analytics and real-world evidence, supported by our deep experience in research and consulting in healthcare and life sciences.
Our range of services includes:
Providing expert analysis and opinions in pre-litigation consulting and post-litigation testimony.
Application of economic theory and methodologies to issues pertaining to litigation.
Calculation of the reasonable fair market value of costs attributable to specific factors or events.
Calculation of the reasonable and fair market value of past and future medical bills and expenses.
Coding of medical services to standard billing codes, such as CPT codes.
Evaluation of the medical necessity and reasonable and fair market value of future care estimates and life care plans.
Calculation of life expectancy, work-life expectancy, and productivity based on pre-existing comorbid medical conditions or injuries attributable to specific events.
Calculation of the reasonable and fair market value of wage losses or workers' compensation claims.
Calculation of expected Medicare and state Medicaid payments for specific scenarios and services.
Economic analysis of various aspects of medical products liability, including attributable costs and damages, abatement costs, monitoring costs, demand & supply models, causation models, and allocation models.
Analysis of the reasonable and fair market value of past and future medical expenses, including life care plans.
Economic analysis of breaches of contract, financial losses, and operational failures.
Calculation of net present value of future losses and expenses, using inflation rates and discount rates.
Economic analysis of trademark infringement, antitrust, competitive practices, barriers to entry and exit, and other aspects of industrial organization and behavior.
We serve a wide variety of clients throughout the U.S. and globally, including law firms, manufacturers, healthcare companies, and insurance companies. We have applied our expertise in litigation support to a variety of industries, including transportation, manufacturing, hospitality, construction, pharmaceuticals, medical devices, insurance, medical care, and finance.
Examples of engagements include:

In personal injury and product liability matters, claimed medical losses and damages are often expressed as their original charged or billed amounts. While this might make sense in many industries, it doesn’t make sense in the health industry. Charges for the exact same service in the exact same geographic area vary substantially, even after statistically adjusting for differences in input prices (like wages) and patient characteristics. This is because of a fundamental disconnect between medical care prices and the associated value of those services. Why the disconnect? Three reasons. First, as the U.S. health care system grew rapidly following World War II, the industry was largely organized as non-profit. As the industry expanded, policymakers expected non-profit entities to offer sufficient levels of “charity” care to justify their tax-exempt status; that is, to show evidence of “community benefit.” One way for healthcare providers to report high levels of charity care was to keep their charges high, accept lower rates on a per case basis, and classify the difference as either charity care or bad debt.
Read more...In the upcoming book The Economics of Pain (Palgrave Macmillan), Schneider provides an in-depth analysis of the U.S. opioid crisis from the perspective of economics and medical products liability. One of the topics explored in the 2026 book is the development of a “cost ceiling model” based on the extensive literature on the attributable costs of the opioid crisis. In litigation the concept of damages often aligns with what health researchers and health economists typically refer to as attributable costs. The methodological approach was to make use of the peer reviewed literature on opioid attributable costs, adjusting those data to reflect the costs at issue in the opioid multi-district litigation, which is focused on prescription opioids and costs incurred by state and local governments. The goal was to calculate an “attributable cost ceiling,” which is the most likely attributable amount faced by state and local governments. A meta-analysis was conducted of peer reviewed published studies that estimated costs associated with healthcare, the criminal justice system, and social and family assistance programs.
Read more...